Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 174855-57-3 | MDL No. : | MFCD05864664 |
Formula : | C16H22N2O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | FGJACYJASSSXNJ-UHFFFAOYSA-N |
M.W : | 290.36 g/mol | Pubchem ID : | 6490990 |
Synonyms : |
|
Num. heavy atoms : | 21 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.5 |
Num. rotatable bonds : | 5 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 89.03 |
TPSA : | 49.85 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.53 cm/s |
Log Po/w (iLOGP) : | 2.98 |
Log Po/w (XLOGP3) : | 2.17 |
Log Po/w (WLOGP) : | 1.79 |
Log Po/w (MLOGP) : | 1.53 |
Log Po/w (SILICOS-IT) : | 1.88 |
Consensus Log Po/w : | 2.07 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.89 |
Solubility : | 0.375 mg/ml ; 0.00129 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.85 |
Solubility : | 0.41 mg/ml ; 0.00141 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.02 |
Solubility : | 0.277 mg/ml ; 0.000953 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.31 |
Signal Word: | Warning | Class: | |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | |
Hazard Statements: | H317-H319 | Packing Group: | |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | Stage #1: With aminosulfonic acid In 1,4-dioxane; water at 4℃; for 0.5 h; Stage #2: With sodium chlorite In 1,4-dioxane; water |
An alternative method for preparing this intermediate is as follows. 4-(2-Formyl- phenyl)-piperazine-l-carboxylic acid tert-buty\\ ester (0.50 g, 1.72 mmol) is dissolved in 80 mL of dioxane and 20 mL of H2O. The mixture is cooled to 4° C. To this is added sulfamic acid (1.36 g, 14.00 mmol) in one portion. The mixture is stirred for an additional 30 min. To this is added 3 mL of a solution of NaClO2 (0.343 g, 3.80 mmol) in a dropwise manner. The reaction is quenched reaction with addition of 50 mL of H2O and 50 mL of brine. The mixture is extracted with 3x100 mL of CH2Cl2. The organic phase is washed with 2x50 niL of brine, dried (MgSO4), filtered and concentrated to give 500 mg of 4-(2-carboxy-phenyl)-piperazine-l-carboxylic acid tert-butyl ester, 95 percent yield. |
[ 197638-83-8 ]
1-Boc-4-(4-Formylphenyl)piperazine
Similarity: 0.93
[ 1257849-25-4 ]
1-Boc-4-(3-Formylphenyl)piperazine
Similarity: 0.92
[ 350684-49-0 ]
tert-Butyl 4-(4-aminobenzoyl)piperazine-1-carboxylate
Similarity: 0.88
[ 927676-52-6 ]
tert-Butyl 4-(4-methylpiperazin-1-yl)benzylcarbamate
Similarity: 0.88
[ 162046-66-4 ]
4-(4-(tert-Butoxycarbonyl)piperazin-1-yl)benzoic acid
Similarity: 0.86
[ 197638-83-8 ]
1-Boc-4-(4-Formylphenyl)piperazine
Similarity: 0.93
[ 1257849-25-4 ]
1-Boc-4-(3-Formylphenyl)piperazine
Similarity: 0.92
[ 391668-75-0 ]
tert-Butyl 6-formylindoline-1-carboxylate
Similarity: 0.84
[ 343306-50-3 ]
tert-Butyl 4-(3-formyl-4-hydroxyphenyl)piperazine-1-carboxylate
Similarity: 0.83
[ 1446332-69-9 ]
tert-Butyl 4-(4-formyl-3-hydroxyphenyl)piperazine-1-carboxylate
Similarity: 0.82
[ 197638-83-8 ]
1-Boc-4-(4-Formylphenyl)piperazine
Similarity: 0.93
[ 1257849-25-4 ]
1-Boc-4-(3-Formylphenyl)piperazine
Similarity: 0.92
[ 350684-49-0 ]
tert-Butyl 4-(4-aminobenzoyl)piperazine-1-carboxylate
Similarity: 0.88
[ 927676-52-6 ]
tert-Butyl 4-(4-methylpiperazin-1-yl)benzylcarbamate
Similarity: 0.88
[ 162046-66-4 ]
4-(4-(tert-Butoxycarbonyl)piperazin-1-yl)benzoic acid
Similarity: 0.86
[ 197638-83-8 ]
1-Boc-4-(4-Formylphenyl)piperazine
Similarity: 0.93
[ 1257849-25-4 ]
1-Boc-4-(3-Formylphenyl)piperazine
Similarity: 0.92
[ 350684-49-0 ]
tert-Butyl 4-(4-aminobenzoyl)piperazine-1-carboxylate
Similarity: 0.88
[ 927676-52-6 ]
tert-Butyl 4-(4-methylpiperazin-1-yl)benzylcarbamate
Similarity: 0.88
[ 162046-66-4 ]
4-(4-(tert-Butoxycarbonyl)piperazin-1-yl)benzoic acid
Similarity: 0.86